BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 10223876)

  • 1. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Sarkodee-Adoo C; Gojo I; Heyman MR
    N Engl J Med; 1999 Apr; 340(17):1368; author reply 1369. PubMed ID: 10223876
    [No Abstract]   [Full Text] [Related]  

  • 2. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
    N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
    Gerritsen HE; Turecek PL; Schwarz HP; Lämmle B; Furlan M
    Thromb Haemost; 1999 Nov; 82(5):1386-9. PubMed ID: 10595623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura].
    Masset C; Dubois B; Rorive G
    Rev Med Liege; 2002 Jan; 57(1):33-9. PubMed ID: 11899496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic thrombocytopenic purpura: a simpler diagnosis at last?
    Mannucci PM
    Thromb Haemost; 1999 Nov; 82(5):1380-1. PubMed ID: 10595621
    [No Abstract]   [Full Text] [Related]  

  • 6. Not known from ADAM(TS-13)--novel insights into the pathophysiology of thrombotic microangiopathies.
    Wolf G
    Nephrol Dial Transplant; 2004 Jul; 19(7):1687-93. PubMed ID: 15128885
    [No Abstract]   [Full Text] [Related]  

  • 7. The "cutting" edge: von Willebrand factor-cleaving protease activity in thrombotic microangiopathies.
    Haspel RL; Jarolím P
    Transfus Apher Sci; 2005 Apr; 32(2):177-84. PubMed ID: 15784452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress on TTP/HUS diagnosis with analysis of VWF-cleaving protease activation].
    Fujimura Y
    Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):451-9. PubMed ID: 15052802
    [No Abstract]   [Full Text] [Related]  

  • 9. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Warwicker P; Goodship JA; Goodship TH
    N Engl J Med; 1999 Apr; 340(17):1368-9. PubMed ID: 10223877
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.
    Tsai HM; Lian EC
    N Engl J Med; 1998 Nov; 339(22):1585-94. PubMed ID: 9828246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAMTS13, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome.
    George JN
    Curr Hematol Rep; 2005 May; 4(3):167-9. PubMed ID: 15865866
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombotic thrombocytopenic purpura: advances in pathophysiology, diagnosis, and treatment--introduction.
    Lämmle B; George JN
    Semin Hematol; 2004 Jan; 41(1):1-3. PubMed ID: 14727253
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular mechanisms in thrombotic thrombocytopenic purpura.
    Tsai HM
    Semin Thromb Hemost; 2004 Oct; 30(5):549-57. PubMed ID: 15497097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Remuzzi G; Galbusera M; Noris M; Canciani MT; Daina E; Bresin E; Contaretti S; Caprioli J; Gamba S; Ruggenenti P; Perico N; Mannucci PM;
    Blood; 2002 Aug; 100(3):778-85. PubMed ID: 12130486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
    Furlan M
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic thrombocytopenic purpura attributable to von Willebrand factor-cleaving protease inhibitor in an 8-year-old boy.
    Robson WL; Tsai HM
    Pediatrics; 2002 Feb; 109(2):322-5. PubMed ID: 11826215
    [No Abstract]   [Full Text] [Related]  

  • 17. [Thrombotic thrombocytopenic purpura].
    Hasegawa Y; Nagasawa T
    Ryoikibetsu Shokogun Shirizu; 2000; (31):152-4. PubMed ID: 11269041
    [No Abstract]   [Full Text] [Related]  

  • 18. Inappropriate use of positive predictive value in describing the rapid collagen binding assay for von Willebrand factor cleaving protease.
    Knovich MA; Case D; Owen J
    Thromb Haemost; 2003 Apr; 89(4):768-9. PubMed ID: 12669136
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet activation and the formation of the platelet plug: deficiency of ADAMTS13 causes thrombotic thrombocytopenic purpura.
    Tsai HM
    Arterioscler Thromb Vasc Biol; 2003 Mar; 23(3):388-96. PubMed ID: 12615692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Von Willebrand factor-cleaving protease activity and proteolysis of von Willebrand factor in bone marrow transplant-associated thrombotic microangiopathy.
    Arai S; Allan C; Streiff M; Hutchins GM; Vogelsang GB; Tsai HM
    Hematol J; 2001; 2(5):292-9. PubMed ID: 11920264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.